Dr Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion in the US market

Dr Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion in the US market

The equivalent Durezol brand and generic had U.S. sales of approximately $40 million MAT for the most recent twelve months ending in November 2022 according to IQVIA

FPJ Web DeskUpdated: Friday, January 27, 2023, 12:35 PM IST
article-image
Dr Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion in the US market | Image: Dr. Reddy's (Representative)

Dr. Reddy’s Laboratories Ltd, today announced the launch of Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05%, a therapeutic generic equivalent to Durezol (Difluprednate Ophthalmic Emulsion 0.05%) in the U.S. market, via an exchange filing.

The announcement is following the approval by the U.S. Food and Drug Administration (USFDA).

The Durezol brand and generic had U.S. sales of approximately $40 million MAT for the most recent twelve months ending in November 2022 according to IQVIA.

Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05% is available in 5 ml bottles in case packs of 24.

RECENT STORIES

Attention Debit Card Holders, Your Maintenance Charges Are Set To Spike: THIS Bank Has Revised The...

Attention Debit Card Holders, Your Maintenance Charges Are Set To Spike: THIS Bank Has Revised The...

Rock Solid: Citroen Basalt Vision Revealed

Rock Solid: Citroen Basalt Vision Revealed

Trade With Speed: India Launches World's Fastest T+0 Trade Settlement; Check Out The 25 Listed...

Trade With Speed: India Launches World's Fastest T+0 Trade Settlement; Check Out The 25 Listed...

Century Textile Shares Rocket Bullishly; Surge Over 10%

Century Textile Shares Rocket Bullishly; Surge Over 10%

Adani's Copper Unit In Mundra Begins Operations

Adani's Copper Unit In Mundra Begins Operations